ECSP003525A - IL-8 IV RECEIVER ANTAGONISTS - Google Patents
IL-8 IV RECEIVER ANTAGONISTSInfo
- Publication number
- ECSP003525A ECSP003525A EC2000003525A ECSP003525A ECSP003525A EC SP003525 A ECSP003525 A EC SP003525A EC 2000003525 A EC2000003525 A EC 2000003525A EC SP003525 A ECSP003525 A EC SP003525A EC SP003525 A ECSP003525 A EC SP003525A
- Authority
- EC
- Ecuador
- Prior art keywords
- receiver antagonists
- antagonists
- receiver
- chemokine
- interleukin
- Prior art date
Links
- 108090001007 Interleukin-8 Proteins 0.000 title abstract 3
- 239000005557 antagonist Substances 0.000 title 1
- 102000004890 Interleukin-8 Human genes 0.000 abstract 2
- 235000013877 carbamide Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- -1 phenyl ureas Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Esta invención se refiere a nuevas fenil-ureas útiles en el tratamiento de estados de enfermedades mediados por la quimiocina interleucina-8(IL-8)This invention relates to novel phenyl ureas useful in the treatment of disease conditions mediated by interleukin-8 chemokine (IL-8)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13967499P | 1999-06-16 | 1999-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP003525A true ECSP003525A (en) | 2002-01-25 |
Family
ID=22487784
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2000003525A ECSP003525A (en) | 1999-06-16 | 2000-06-12 | IL-8 IV RECEIVER ANTAGONISTS |
EC2000003528A ECSP003528A (en) | 1999-06-16 | 2000-08-14 | ANTAGONISTS OF THE RECEIVER OF IL - 8 VI |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2000003528A ECSP003528A (en) | 1999-06-16 | 2000-08-14 | ANTAGONISTS OF THE RECEIVER OF IL - 8 VI |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1191934A4 (en) |
JP (1) | JP2003501471A (en) |
KR (1) | KR20020009635A (en) |
CN (1) | CN1494424A (en) |
AR (1) | AR029368A1 (en) |
AU (1) | AU766086B2 (en) |
BR (1) | BR0010985A (en) |
CA (1) | CA2377397A1 (en) |
CZ (1) | CZ20014490A3 (en) |
EC (2) | ECSP003525A (en) |
HK (1) | HK1044716A1 (en) |
HU (1) | HUP0202019A3 (en) |
IL (1) | IL146214A0 (en) |
MX (1) | MXPA01013287A (en) |
NO (1) | NO20016065D0 (en) |
NZ (1) | NZ515232A (en) |
PE (1) | PE20010319A1 (en) |
PL (1) | PL352218A1 (en) |
TR (1) | TR200103690T2 (en) |
UY (1) | UY26209A1 (en) |
WO (1) | WO2000076516A1 (en) |
ZA (1) | ZA200110203B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6642215B2 (en) * | 2001-05-24 | 2003-11-04 | Leo Pharma A/S | Method of modulating NF-kB activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2060682T3 (en) * | 1988-03-30 | 1994-12-01 | Warner Lambert Co | N - ((FENIL (2,6-DISUBSTITUTED)) - N'-ARIL) UREAS AS ANTI-HYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS. |
US5780483A (en) * | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
AR008290A1 (en) * | 1996-08-15 | 1999-12-29 | Smithkline Beecham Corp | NEW COMPOUNDS CONTAINING GUANIDINE USEFUL AS ANTAGONISTS OF IL-8 RECEPTORS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS AND PROCEDURE FOR THE PREPARATION OF INTERMEDIARIES. |
-
2000
- 2000-06-12 EC EC2000003525A patent/ECSP003525A/en unknown
- 2000-06-14 AR ARP000102925A patent/AR029368A1/en not_active Application Discontinuation
- 2000-06-14 PE PE2000000589A patent/PE20010319A1/en not_active Application Discontinuation
- 2000-06-14 UY UY26209A patent/UY26209A1/en not_active Application Discontinuation
- 2000-06-16 KR KR1020017016140A patent/KR20020009635A/en not_active Application Discontinuation
- 2000-06-16 TR TR2001/03690T patent/TR200103690T2/en unknown
- 2000-06-16 AU AU57482/00A patent/AU766086B2/en not_active Ceased
- 2000-06-16 JP JP2001502849A patent/JP2003501471A/en not_active Withdrawn
- 2000-06-16 PL PL00352218A patent/PL352218A1/en not_active Application Discontinuation
- 2000-06-16 NZ NZ515232A patent/NZ515232A/en unknown
- 2000-06-16 EP EP00942933A patent/EP1191934A4/en not_active Withdrawn
- 2000-06-16 WO PCT/US2000/016813 patent/WO2000076516A1/en not_active Application Discontinuation
- 2000-06-16 HU HU0202019A patent/HUP0202019A3/en unknown
- 2000-06-16 IL IL14621400A patent/IL146214A0/en unknown
- 2000-06-16 BR BR0010985-1A patent/BR0010985A/en not_active IP Right Cessation
- 2000-06-16 MX MXPA01013287A patent/MXPA01013287A/en unknown
- 2000-06-16 CN CNA008089205A patent/CN1494424A/en active Pending
- 2000-06-16 CZ CZ20014490A patent/CZ20014490A3/en unknown
- 2000-06-16 CA CA002377397A patent/CA2377397A1/en not_active Abandoned
- 2000-08-14 EC EC2000003528A patent/ECSP003528A/en unknown
- 2000-12-12 ZA ZA200110203A patent/ZA200110203B/en unknown
-
2001
- 2001-12-12 NO NO20016065A patent/NO20016065D0/en not_active Application Discontinuation
-
2002
- 2002-08-27 HK HK02106332.2A patent/HK1044716A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1191934A4 (en) | 2004-02-04 |
ECSP003528A (en) | 2002-01-25 |
ZA200110203B (en) | 2002-09-11 |
HUP0202019A2 (en) | 2002-10-28 |
CA2377397A1 (en) | 2000-12-21 |
IL146214A0 (en) | 2002-07-25 |
PE20010319A1 (en) | 2001-05-24 |
TR200103690T2 (en) | 2002-05-21 |
HUP0202019A3 (en) | 2003-03-28 |
JP2003501471A (en) | 2003-01-14 |
HK1044716A1 (en) | 2002-11-01 |
AU5748200A (en) | 2001-01-02 |
NO20016065L (en) | 2001-12-12 |
UY26209A1 (en) | 2000-12-29 |
EP1191934A1 (en) | 2002-04-03 |
AU766086B2 (en) | 2003-10-09 |
CN1494424A (en) | 2004-05-05 |
AR029368A1 (en) | 2003-06-25 |
WO2000076516A1 (en) | 2000-12-21 |
NZ515232A (en) | 2004-02-27 |
BR0010985A (en) | 2002-03-26 |
NO20016065D0 (en) | 2001-12-12 |
MXPA01013287A (en) | 2002-06-04 |
KR20020009635A (en) | 2002-02-01 |
PL352218A1 (en) | 2003-08-11 |
CZ20014490A3 (en) | 2002-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE419845T1 (en) | IL-8 RECEPTOR ANTAGONISTS | |
NO986110L (en) | IL-8 receptor antagonists | |
TR200101772T2 (en) | Hydroxy diphenyl urea sulfonamides as IL-8 Receptor antagonists | |
CY1106514T1 (en) | IL-8 RECEPTOR ANTAGONISTS | |
TR199901710T2 (en) | IL-8 receptor antagonists. | |
TR199900318T2 (en) | IL-8 receptor antagonists. | |
CR8659A (en) | PGD2 RECEIVER ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
UY26601A1 (en) | IL-8 RECEPTOR ANTAGONISTS | |
PA8456601A1 (en) | 4-AMINOPYROL (3,2-D) PIRIMIDINES AS AN ANTAGONISTS OF THE NEUROPEPTIDE RECEPTOR AND | |
PT1129096E (en) | CRF RECEPTOR ANTAGONISTS AND METHODS OF TREATMENT RELATED TO THEM | |
ATE424194T1 (en) | ADENOSINE A2A RECEPTOR ANTAGONISTS IN COMBINATION WITH COMPOUNDS WITH NEUROTROPHIC ACTIVITY IN THE TREATMENT OF PARKINSON'S DISEASE | |
AP1548A (en) | Il-8 Receptor Antagonists. | |
AR024350A1 (en) | ANTAGONISTS OF IL-8 RECEIVERS | |
ECSP003525A (en) | IL-8 IV RECEIVER ANTAGONISTS | |
WO2001068569A3 (en) | Il-8 receptor antagonists | |
BR0010843A (en) | Il-8 receptor antagonists | |
MY143477A (en) | Il-8 receptor antagonists | |
UY26206A1 (en) | IL-8 RECEPTOR ANTAGONISTS. | |
ECSP003527A (en) | IL RECEIVER ANTAGONISTS - 8 V | |
AP2002002606A0 (en) | IL-8 receptor antagonists. | |
ECSP003529A (en) | ANTAGONISTS OF THE RECEIVER OF IL - 8 VII | |
BR0010863A (en) | Il-8 receptor antagonists | |
WO2001064165A3 (en) | Il-8 receptor antagonists | |
WO2001076530A3 (en) | Il-8 receptor antagonists | |
BR0214613A (en) | N-ureide piperidines as ccr-3 receptor antagonists |